CTX-2026
Product Specifications
UNSPSC Description
CTX-2026 is a fully human antibody that binds to CD277. CTX-2026 shows an anti-tumor effect on ovarian tumor models. CTX-2026 can be used for the research of cancer[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-2026.html
Purity
98.95
Solubility
10 mM in DMSO
Smiles
[3H][C][X2026]
References & Citations
[1]Payne KK, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science. 2020 Aug 21;369(6506):942-949.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99179/CTX-2026-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99179/CTX-2026-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2090565-01 0.1 mL
Monoclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121)
Ask
View Details MBS2090565-02 0.2 mL
Monoclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121)
Ask
View Details 
MBS2090565-03 0.5 mL
Monoclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121)
Ask
View Details MBS2090565-04 1 mL
Monoclonal Antibody to Vascular Endothelial Growth Factor 121 (VEGF121)
Ask
View Details